Stay updated on Safety and Tolerability of VK2809 in Hypercholesterolemia Clinical Trial

Sign up to get notified when there's something new on the Safety and Tolerability of VK2809 in Hypercholesterolemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Tolerability of VK2809 in Hypercholesterolemia Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T18:55:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study content with an access-restricted message. The update includes a minimal error page header and footer consistent with the site's layout.
    Difference
    17%
    Check dated 2026-09-20T20:19:36.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page reflects an updated system revision number (v3.6.6) replacing the previous v3.6.5. This indicates a software version update and does not change the study information or navigation.
    Difference
    0.1%
    Check dated 2026-08-30T21:43:17.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    An HTML error page is added, indicating the requested study record is currently unavailable and replacing the usual content; deletions remove a large portion of study-record metadata and history labels.
    Difference
    16%
    Check dated 2026-08-09T08:33:18.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a minor maintenance update without changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T17:56:30.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The Additional Relevant MeSH Terms now include Steatotic Liver Disease and no longer include Fatty Liver Disease. This updates the liver disease terminology associated with the study for indexing and discovery.
    Difference
    0.1%
    Check dated 2026-07-18T15:47:21.000Z thumbnail image

Stay in the know with updates to Safety and Tolerability of VK2809 in Hypercholesterolemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of VK2809 in Hypercholesterolemia Clinical Trial page.